Christa M Lam, Zihai Li, Dan Theodorescu, Xue Li. Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors.Bladder cancer (Amsterdam, Netherlands). 2022, 8 (3): 241-254
Roy Mano, Benedikt Hoeh, Renzo G DiNatale, Alejandro Sanchez, Nicole E Benfante, Ed Reznik, Mario M Leitao, Alexander N Shoushtari, Alvin Goh, S Machele Donat, Harry W Herr, Bernard H Bochner, Guido Dalbagni, Timothy F Donahue. Urethral Melanoma - Clinical, Pathological and Molecular Characteristics.Bladder cancer (Amsterdam, Netherlands). 2022, 8 (3): 291-301
Khyati Meghani, Lauren Folgosa Cooley, Andrea Piunti, Joshua J Meeks. Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer.Bladder cancer (Amsterdam, Netherlands). 2022, 8 (2): 101-112
Sounak Gupta, Chad M Vanderbilt, Yanming Zhang, Satish K Tickoo, Samson W Fine, Anuradha Gopalan, Ying-Bei Chen, Sahussapont J Sirintrapun, Min Yuen Teo, Samuel A Funt, Gopa Iyer, Jonathan E Rosenberg, Dean F Bajorin, Bernard H Bochner, Eugene J Pietzak, Dara S Ross, Marc Ladanyi, John C Cheville, David B Solit, Victor E Reuter, Hikmat A Al-Ahmadie. () Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.Bladder cancer (Amsterdam, Netherlands). 2021, 7 (4): 395-400
Syed M Alam, Carrie Michel, Hilary Robertson, Juliana T Camargo, Brenda Linares, Jeffrey Holzbeierlein, Jill Hamilton-Reeves. Optimizing Nutritional Status in Patients Undergoing Radical Cystectomy: A Systematic Scoping Review.Bladder cancer (Amsterdam, Netherlands). 2021, 7 (4): 449-461
Ryan M Reyes, Emily Rios, Shane Barney, Cory M Hugen, Joel E Michalek, Yair Lotan, Edward M Messing, Robert S Svatek. A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.Bladder cancer (Amsterdam, Netherlands). 2021, 7 (3): 285-295
Andrea Kokorovic, Mary E Westerman, Kate Krause, Mike Hernandez, Nathan Brooks, Colin P N Dinney, Ashish M Kamat, Neema Navai. Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate.Bladder cancer (Amsterdam, Netherlands). 2021, 7 (2): 243-252
. Erratum: Outcomes of Trimodal Therapy for cT2-3 Urothelial Carcinoma in a Racially Diverse Population: A Single Institution Experience in the Bronx.Bladder cancer (Amsterdam, Netherlands). 2021, 7 (1): 111-112
Ciro Andolfi, Jeffrey C Bloodworth, Apostolos Papachristos, Randy F Sweis. The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.Bladder cancer (Amsterdam, Netherlands). 2020, 6 (3): 225-235
Sylvia H J Jochems, Anke Wesselius, Maurice P Zeegers. Erratum to: Total Fluid Intake and the Risk of Recurrence in Patients with Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.Bladder cancer (Amsterdam, Netherlands). 2020, 6 (3): 401
Peter Boxley, Melissa Plets, Thomas W Flaig. Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer.Bladder cancer (Amsterdam, Netherlands). 2020, 6 (2): 123-129
Alexander Yang, Christopher N Cross, Jeffrey P Townsend. Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers.Bladder cancer (Amsterdam, Netherlands). 2020, 6 (2): 211-213
Leonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, John L Gore, George R Schade, Andrew C Hsieh, John K Lee, Todd Yezefski, Evan Y Yu, Michael T Schweizer, Heather H Cheng, Sarah P Psutka, Daniel W Lin, Maria S Tretiakova, Funda Vakar-Lopez, Robert B Montgomery, Jonathan L Wright. Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes.Bladder cancer (Amsterdam, Netherlands). 2020, 6 (1): 71-81